Assignee
SIRNAOMICS INC
US·7 granted patents·36 pending applications·28 citations·filing 2008–2025
Top patents by PatentIndex Score
43 records- 0193US11058779B2Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infectionSIRNAOMICS INC·Filed 2016·Granted Jul 13, 2021·18 cites·20 claims
- 0287US12006500B2Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)SIRNAOMICS INC·Filed 2021·Granted Jun 11, 2024·2 cites·16 claims
- 0385US12054714B2Peptide docking vehicle for targeted nucleic acid deliverySIRNAOMICS INC·Filed 2020·Granted Aug 6, 2024·1 cites·13 claims
- 0484USRE46873EMulti-targeted RNAi therapeutics for scarless wound healing of skinSIRNAOMICS INC·Filed 2008·Granted May 29, 2018·5 cites·21 claims
- 0581US11697813B2Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosisSIRNAOMICS INC·Filed 2017·Granted Jul 11, 2023·2 cites·11 claims
- 0674US2025313837A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 0773US2025313846A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 0870US2025249027A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 0969US12378552B2Oligomeric compound for inhibiting expression of factor XISIRNAOMICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·20 claims
- 1069US2025027086A1COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS USING MODIFIED siRNA-GEM AGENTSSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 1168US2023365969A1Methods for inducing adipose tissue remodeling using rnai therapeuticsSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1268US2024158794A1NUCLEOSIDE CONTAINING siRNAS FOR TREATING VIRAL DISEASESSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1367US2024175032A1Compositions and methods for inhibiting expression of pcsk9SIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1467US2023257753A1Products and compositionsSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1567US2023392154A1Targeted nucleic acid therapy for hepatitis bSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1665US2023355656A1Compositions and methods for treatment of skin cancersSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1764US2024108741A1COMBINATION siRNA AND PEPTIDE DOCKING VEHICLE (PDoV) COMPOSITIONS AND METHODS OF THEIR USE FOR IMPROVED REGULATION AND FUNCTIONALITYSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1863US2023250432A1siRNA-Copolymer Compositions And Methods Of Use For Treatment Of Liver CancerSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 1962US2023323358A1COMPOSITION AND USE OF siRNAs AGAINST VEGFR2 AND TGF-BETA1 IN COMBINATION THERAPY FOR CANCERSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 2062US2022282258A1CO-DELIVERY OF TGF-B siRNA AND PDL1 siRNA TO TREAT CANCERSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2161US2022145301A1siRNA/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral InfectionSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2261US2023089502A1Products and compositionsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2361US2022411802A1METHODS OF CANCER TREATMENT BY DELIVERY OF siRNAs AGAINST NSD3SIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2461US2023089915A1Products and compositionsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2560US2022331441A1Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid TherapeuticsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2659US2021324384A1SILENCING TGF-BETA 1 and COX2 USING siRNAs DELIVERED in a POLYPEPTIDE NANOPARTICLE ALONE and in COMBINATION with IMMUNE CHECKPOINT INHIBITORS to TREAT CANCERSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2759US2022387599A1Oligonucleotides with nucleoside analogsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2858US2021332358A1MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOFSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2958US2024110187A1METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST ORF1AB and N-ProteinSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 3057US2022288228A1METHODS OF CANCER TREATMENT BY DELIVERY OF siRNAs AGAINST BCLXL AND MCL1 USING A POLYPEPTIDE NANOPARTICLESIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3156US2021371861A1Multi-Targeting Nucleic Acid Constructs Composed Of Multiple Oligonucleotides That Modulate Gene Expression Through Complimentary Interactions With TargetsSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 3256US2025263704A1Nucleic acid-polypeptide nano-pharmaceutical compostion for treating and preventing human papilloma virus infectionSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3356US2023097985A1Nanoparticle formulations formed from histidine-lysine copolymersSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3455US2023257751A1METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST TGFB1 AND COX2SIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 3555US2022333108A1Combinations of sirnas with sirnas against sulf2 or gpc3 for use in treating cancerSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3654US2026092275A1Products and compositionsSIRNAOMICS INC·Filed 2025·Application pending·0 cites
- 3753US2021162067A1Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid TherapeuticsSIRNAOMICS INC·Filed 2020·Application pending·0 cites
- 3853US2023233476A1Nanoparticle pharmaceutical compositions with reduced nanoparticle size and improved polydispersity indexSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3952US2023121879A1Methods for preparing nanoparticle compositions containing histidine-lysine copolymersSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 4052US2022054645A1Targeted Delivery of Therapeutic MoleculesSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 4150US2018369273A1Pharmaceutical Composition and Applications ThereofSIRNAOMICS INC·Filed 2016·Application pending·0 cites
- 4247US9868952B2Compositions and methods for “resistance-proof” SiRNA therapeutics for influenzaSIRNAOMICS INC·Filed 2013·Granted Jan 16, 2018·0 cites·22 claims
- 4337US2017233742A1Compositions Comprising Small Interfering RNA Molecules for Prevention and Treatment of Ebola Virus DiseaseSIRNAOMICS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →